Iron Deficiency Anemia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Shield Therapeutics, Zeria Pharma, Keros Therapeutics

DelveInsight’s “Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Iron Deficiency Anemia, historical and forecasted epidemiology as well as the Iron Deficiency Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Iron Deficiency Anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Iron Deficiency Anemia Market Forecast

Some of the key facts of the Iron Deficiency Anemia Market Report: 

• The Iron Deficiency Anemia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In 2021, there were 30,940,556 caes of Iron Deficiency Anemia in the 7MM as a whole. These cases are expected to rise during the projection period [2019-2032]
• Japan reported the largest prevalence of Iron Deficiency Anemia cases in the 7MM, totaling 12,021,969 cases. The United States came in second with 9,379,955 frequent cases in the year 2021
• In 2021, 9,303,679, 930,368 and 1,500,063 cases of Iron Deficiency Anemia in the 7MM will have had first-line oral iron therapy, second-line oral iron therapy, or IV therapy, respectively
• Key Iron Deficiency Anemia Companies: Pharmacosmos A/S, Tigermed Consulting Co., Ltd, Shield Therapeutics, Zeria Pharma, Keros Therapeutics, Inc., AMAG Pharma, JW Pharmaceutical, and others
• Key Iron Deficiency Anemia Therapies: iron isomaltoside 1000 (Monofer®), Ferric carboxymaltose, Ferric Maltol, Z-213, KER-047, Ferumoxytol, venoferrum(iron sucrose), Z-213, and others
• The Iron Deficiency Anemia epidemiology based on gender analyzed that Iron Deficiency Anemia affects more females as compared to males
• The Iron Deficiency Anemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Iron Deficiency Anemia pipeline products will significantly revolutionize the Iron Deficiency Anemia market dynamics.

Get a Free sample for the Iron Deficiency Anemia Market Report 

https://www.delveinsight.com/report-store/iron-deficiency-anemia-market

Iron Deficiency Anemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Iron Deficiency Anemia Epidemiology Segmentation:

The Iron Deficiency Anemia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Iron Deficiency Anemia
• Prevalent Cases of Iron Deficiency Anemia by severity
• Gender-specific Prevalence of Iron Deficiency Anemia
• Diagnosed Cases of Episodic and Chronic Iron Deficiency Anemia

Download the report to understand which factors are driving Iron Deficiency Anemia epidemiology trends @ Iron Deficiency Anemia Epidemiology Forecast

Iron Deficiency Anemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Iron Deficiency Anemia market or expected to get launched during the study period. The analysis covers Iron Deficiency Anemia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Iron Deficiency Anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Iron Deficiency Anemia Therapies and Key Companies

• iron isomaltoside 1000 (Monofer®): Pharmacosmos A/S
• Ferric carboxymaltose: Tigermed Consulting Co., Ltd
• Ferric Maltol: Shield Therapeutics
• Z-213: Zeria Pharma
• KER-047: Keros Therapeutics, Inc.
• Ferumoxytol: AMAG Pharma
• venoferrum(iron sucrose): JW Pharmaceutical
• Z-213: Zeria Pharma

Discover more about therapies set to grab major Iron Deficiency Anemia market share @ Iron Deficiency Anemia Treatment Market

Iron Deficiency Anemia Market Drivers

• Increasing changes in lifestyle
• Increasing cases of anemia
• Growth in geriatric population

Iron Deficiency Anemia Market Barriers

• Extensive usage of over-the-counter (OTC) medications
• Availability of generics
• Lack of robust pipeline

Scope of the Iron Deficiency Anemia Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Iron Deficiency Anemia Companies: Pharmacosmos A/S, Tigermed Consulting Co., Ltd, Shield Therapeutics, Zeria Pharma, Keros Therapeutics, Inc., AMAG Pharma, JW Pharmaceutical, and others
• Key Iron Deficiency Anemia Therapies: iron isomaltoside 1000 (Monofer®), Ferric carboxymaltose, Ferric Maltol, Z-213, KER-047, Ferumoxytol, venoferrum(iron sucrose), Z-213, and others
• Iron Deficiency Anemia Therapeutic Assessment: Iron Deficiency Anemia current marketed and Iron Deficiency Anemia emerging therapies
• Iron Deficiency Anemia Market Dynamics: Iron Deficiency Anemia market drivers and Iron Deficiency Anemia market barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Iron Deficiency Anemia Unmet Needs, KOL’s views, Analyst’s views, Iron Deficiency Anemia Market Access and Reimbursement 

To know more about Iron Deficiency Anemia companies working in the treatment market, visit @ Iron Deficiency Anemia Clinical Trials and Therapeutic Assessment

Table of Contents 

1. Iron Deficiency Anemia Market Report Introduction

2. Executive Summary for Iron Deficiency Anemia

3. SWOT analysis of Iron Deficiency Anemia

4. Iron Deficiency Anemia Patient Share (%) Overview at a Glance

5. Iron Deficiency Anemia Market Overview at a Glance

6. Iron Deficiency Anemia Disease Background and Overview

7. Iron Deficiency Anemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Iron Deficiency Anemia 

9. Iron Deficiency Anemia Current Treatment and Medical Practices

10. Iron Deficiency Anemia Unmet Needs

11. Iron Deficiency Anemia Emerging Therapies

12. Iron Deficiency Anemia Market Outlook

13. Country-Wise Iron Deficiency Anemia Market Analysis (2019–2032)

14. Iron Deficiency Anemia Market Access and Reimbursement of Therapies

15. Iron Deficiency Anemia Market Drivers

16. Iron Deficiency Anemia Market Barriers

17.  Iron Deficiency Anemia Appendix

18. Iron Deficiency Anemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services